5-(3-hydroxyphenyl)-5-phenylhydantoin and Chronic Disease

5-(3-hydroxyphenyl)-5-phenylhydantoin has been researched along with Chronic Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goto, W; Higuchi, S; Hirata, K; Ieiri, I; Imayama, S; Ohtsubo, K; Ohyama, Y; Toshitani, A; Yamada, H	1

Trials

1 trial(s) available for 5-(3-hydroxyphenyl)-5-phenylhydantoin and Chronic Disease

Article	Year
The effect of 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) enantiomers, major metabolites of phenytoin, on the occurrence of chronic side effects: in vivo and in vitro studies. Psychiatry and clinical neurosciences, 1995, Volume: 49, Issue:3 Topics: Adolescent; Adult; Aged; Anticonvulsants; Cell Division; Chronic Disease; DNA; Female; Fibroblasts; Humans; Male; Middle Aged; Phenytoin; Stereoisomerism	1995

Article

Year

The effect of 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) enantiomers, major metabolites of phenytoin, on the occurrence of chronic side effects: in vivo and in vitro studies.

Psychiatry and clinical neurosciences, 1995, Volume: 49, Issue:3

Topics: Adolescent; Adult; Aged; Anticonvulsants; Cell Division; Chronic Disease; DNA; Female; Fibroblasts; Humans; Male; Middle Aged; Phenytoin; Stereoisomerism

1995